Baricitinib (Olumiant®) thromboembolic event in patient receiving full-dose anticoagulation

Authors

Alexis A. Vandehey, Advocate Aurora HealthFollow
Megan A. Avery, Advocate Aurora Health
Jennifer A. Esch, Advocate Aurora HealthFollow
Jessica S. Thompson, Advocate Aurora HealthFollow

Recommended Citation

Vandehey AA, Avery MA, Esch J, Thompson JS. Baricitinib (Olumiant®) thromboembolic event in patient receiving full-dose anticoagulation. The Journal of the Pharmacy Society of Wisconsin. 2022;25(4):23-25.

Affiliations

Aurora BayCare Medical Center

Document Type

Article